Upaya Soft Power Diplomacy Tiongkok kepada Indonesia melalui Bantuan Vaksin Sinovac
Keywords:
Softpower, Vaccine Diplomacy, Health Silk Road InitiativeAbstract
This research discusses the implementation of softpower diplomacy by China towards Indonesia regarding Sinovac Vaccine assistance. The research that has been carried out aims to describe the diplomatic relations between China and Indonesia in providing Sinovac vaccine assistance to Indonesia and to analyze the implementation of soft power diplomacy using the Sinovac vaccine as China's form of implementing the Health Silk Road Initiative program. The method that the researcher uses is descriptive qualitative and the writer collects data from library sources and various official links or the mass media. The results of this study indicate that vaccine diplomacy seen during the COVID-19 pandemic varies greatly between countries. China has played an important role in contributing to global vaccine equity, in addition to meeting its domestic demand. Furthermore, as China seeks internationally to address this vaccine inequality through the COVAX network, periphery and semi-periphery countries are lagging behind most of the supplies that core countries have locked down. Lastly, the vaccination cooperation relationship between China and Indonesia is limited access to vaccines, thus, the efforts of the Indonesian government to procure and supply the COVID-19 vaccine in Indonesia by working with a Chinese country to supply vaccine availability.
References
Aktivitas Diplomasi Kesehatan Indonesia-Tiongkok di Masa Pandemi COVID-19” 2021 “https://journal.unpar.ac.id/index.php/Sentris/article/view/5188/3534” diakses hal 286
Ardito Ramdhan, Krisiandi. 2020. Menlu Retno : Bio Farma dan Snovac Teken Kerja sama Ketersediaan 40 Juta Dosis Vaksin Covid-19. https://nasional.kompas.com/read/2020/08/20/21323161/menlu-retno-bio-farma-dan-sinovac-teken-kerja-sama-ketersediaan-40-juta. Bab III Metode Penelitian Menurut Bogdan dan Taylor” 2017 https://eprints.umm.ac.id/35187/4/jiptummpp-gdl-feryhermaw-47916-4-babiii.-x.pdf hal 58
Bab III Metode Penelitian Menurut Nana Sudjana dan R. Ibrahim” http://repository.upi.edu/986/6/T_PK_999684_Chapter3.pdf
china’s COVID-19 Vaccine Diplomacy Reaches 100-plus Countries”
COVID, G. (19). Vaccination Strategy in a Changing World: July 2022 update.
Diplomasi Vaksin Covid-19 dan Budaya Anarki dalam Sistem Internasional” 2021 https://jurnal.dpr.go.id hal 146
Diplomasi Vaksin Covid-19 dan Budaya Anarki dalam Sistem Internasional” 2021 https://jurnal.dpr.go.id hal 146
Hopkins, Johns “What is Coronavirus” https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus
https://lontar.ui.ac.id/file?file=digital/135761-T%2028001-Soft%20power-Pendahuluan.pdf
https://lontar.ui.ac.id/file?file=digital/135761-T%2028001-Soft%20power-Pendahuluan.pdf
Indonesia dan Tiongkok Sepakat Perkuat Kolaborasi untuk Dorong Pemulihan Ekonomi dan Tangkal Pandemi” 2021 https://kemlu.go.id/portal/id/read/2069/berita/indonesia-dan-tiongkok-sepakat-perkuat-kolaborasi-untuk-dorong-pemulihan-ekonomi-dan-tangkal-pandemi
Indonesia Terima Kedatangan 4 Juta Vaksin Sinovac https://www.cnnindonesia.com/nasional/20211101183939-25-715182/indonesia-terima-kedatangan-4-juta-vaksin-sinovac
Jing Zhao. 2020. “COVID-19: Coronavirus Vaccine Development Updates” DOI: 10.3389/fimmu.2020.602256
Kemenkes, R. I. (2021). Strategi Vaksinasi COVID-19 Mulai Dilakukan, Presiden Orang Pertama Penerima Suntikan Vaksin COVID-19.
Kirgizov-Barskii, A. V., & Morozov, V. M. (2022). Vaccine Diplomacy and Vaccine Nationalism. Vaccine.
Kirk Lancaster, Michael Rubin, Mira Rapp- Hooper “Mapping China’s Health Silk Road” 2020.
Krisiandi(Ed). 2020. “Lewat Telepon, Jokowi dan Xi Jinping Bahas Kerja Sama Perjalanan Bisnis dan Kedinasan” https://nasional.kompas.com/read/2020/09/01/16453661/lewat-telepon-jokowi-dan-xi-jinping-bahas-kerja-sama-perjalanan-bisnis-dan.
Kuswaraharja. 2020. “Daftar Negara Yang “Lockdown” Indonesia”. https://travel.detik.com/travel-news/d- 5166580/daftar-negara- yang-lockdown-indonesia.
Lee, S. T. (2021). Vaccine diplomacy: nation branding and China’s COVID-19 soft power play. Place Branding and Public Diplomacy, 1-15.
Lee, Seow Ting.” Vaccine diplomacy: nation branding and China’s COVID-19 soft power play https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259554/
Memahami Konsep Soft Power Diplomacy” 2015 https://www.porosilmu.com/2015/02/memahami-konsep-soft-power-diplomacy.html
Muhammad Khadafi.2020. “Xi Jinping Telepon Jokiwi. Ajak Cari Peluang Kerja Sama di Tengah Pandemi COVID-19” kabar24.bisnis.com/read/20200901/15/1285617/xi-jinping-telepon-jokowi-ajak-cari-peluang-kerja-sama-di-tengah-pandemi-Covid-19.
Nolte Michael T. 2020. “COVID-19: Current and Future Challenges in spine care and education – a worldwide study” https://doi.org/10.1002/jsp2.1122
Nye, Joseph S. 2004, “Soft Power: The Means to Success in World Politics” , https://www.foreignaffairs.com/reviews/capsule-review/2004-05-01/soft-power-meanssuccess-world-politics.
Nye, Joseph. “soft Power”. Foregn Policy. 1990
Pannu, J., & Barry, M. (2021). The state inoculates: Vaccines as soft power. The Lancet Global Health, 9(6), e744-e745.
Pemerintah Provinsi Jawa Barat. 2020. “Bio Farma Siap Produksi 250 juta Vaksin COVID-19” https://jabarprov.go.id/index.php/news/38699/2020/08/04/Bio-Farma-Siap- Produksi-250- Juta-Vaksin-Covid-19.
Politik “Diplomasi Vaksin” dan Hubungan Cina-Indonesia” https://hi.fisipol.ugm.ac.id/berita/diskusi-bulanan-dihi-ugm-politik-diplomasi-vaksin-dan-hubungan-cina-indonesia/
Prof Yanjun Zhang, PhD.2020. “Sefety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase ½ clinical trial” DOI:https://doi.org/10.1016/S1473-3099(20)30843-4.
Purwonugroho.2020. “Kerja sama Bilateral oleh Indoneisa dalam Pengembangan Vaksin COVID-19”
Reuters Staff, 2021 “China’s Sinovac to Double Annual COVID-19 Vaccine Capacitu to 1 Billion Doses” https://www.reuters.com/article/us-health-coronavirus-vaccine-sinovac-idUSKBN29I0Y. Diakses
Samiah Zulfianto, Muhammad Badaruddin, 2021. Anatomi Kerja sama Bilateral Indonesia-China Dalam Pengembangan Vaksin COVID-19. file:///C:/Users/Asus/Downloads/21-Article%20Text-160-1-10-20211202%20(1).pdf
Samiah Zulvianto, Muhammad Bdaruddin. 2021. Anatomi Kerja sama Bilateral Indonesia-China Dalam Pengembangan Vaksin Covid-19. file:///C:/Users/Asus/Downloads/21-Article%20Text-160-1-10-20211202%20(1).pdf
The Health Silk Road: How China Adapts the Belt and Road Initiative to the COVID-19 Pandemic” 2022
Uji Vaksin Covid-19 dari China Hampir final” 2022“https://indonesiabaik.id/infografis/uji-vaksin-Covid-19-dari-china-hampir-final”
Vaksin Sinovac dating, Bagaimana Distribusinya? Ini Penjelasan Tarawan” https://www.kompas.com/sains/read/2020/12/08/070500923/vaksin-sinovac-datang-bagaimana-distribusinya-ini-penjelasan-terawan?page=all
Wicaksono, R. M. T. A. D., Hirawan, F. B., & Ragamustari, S. K. (2022). An Analysis of Indonesia’s Free and Active COVID-19 Vaccine Diplomacy. Jurnal Hubungan Internasional, 11(1), 32-45.
Zacharias Wuragil, Ahmad Fikri. 2020. “Bio Farma akan Produksi Vaksin Covid-19 Untuk CEPI, 100 Juta Dosis Setahun” https://tekno.tempo.co/read/1396528/bio-farma-akan-produksi-vaksin-Covid-19-untuk-cepi-100-juta-dosis-setahun.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pratiwi Hardiningsih Kriswati, Denada Faraswacyen L. Gaol
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Balcony (Budi Luhur Journal of Contemporary Diplomacy) , the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Balcony (Budi Luhur Journal of Contemporary Diplomacy) agree to the following terms:
- Authors retain copyright and grant the Balcony (Budi Luhur Journal of Contemporary Diplomacy) right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Balcony (Budi Luhur Journal of Contemporary Diplomacy) published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
